Navigation Links
Study suggests reduced lung function in infancy associated with wheeze later
Date:2/18/2013

A study in Australia suggests that reduced lung function in infancy was associated with wheezing beyond childhood at 18 years of age, according to a report published Online First by JAMA Pediatrics, a JAMA Network publication.

Abnormal airway function is characteristic of asthma and chronic obstructive airways disease, and other studies have suggested that reduced lung function is already apparent in childhood and tracks through adulthood. However, the relationship between the age of onset of airway dysfunction and wheeze, a symptom of obstructive airways disease, has not been clarified, the authors write in the study background.

The study by David Mullane, M.D., of University College Cork, Ireland, and colleagues included participants from a birth cohort who had been followed from one month to 18 years. At age 18 years, 150 participants were assessed and 37 participants (25 percent) had recent wheeze and 20 (13 percent) were diagnosed with asthma, according to the results.

"To our knowledge, this study is the first to report an association between reduced lung function in infancy and wheeze beyond childhood," the authors note.

In the study, a total of 143 participants were categorized as having persistent wheeze (n=13), later-onset wheeze (n=19), remittent wheeze (n=15) and no wheeze (n=96). Compared with the no-wheeze group, persistent wheeze was independently associated with reduced percentage of predicted maximal flow at functional residual capacity (V'maxFRC, mean reduction 43 percent). Compared with the no-wheeze group, persistent wheeze was also associated with atopy (a predisposition to allergic reactions) in infancy (odds ratio, 7.1); maternal asthma (odds ratio, 6.8) and active smoking (odds ratio, 4.8), according to the results.

"Unexpectedly, we observed that a reduced V'maxFRC at age one month was associated with increased risk for wheeze only in young adults who were also current smokers. These results suggest that reduced early airway function and later exposures such as smoking are important to the cause of obstructive respiratory diseases in young adults. Interventions aimed at preventing young children with asthma symptoms and reduced lung function from smoking might prevent persisting symptoms of obstructive airways disease," the authors comment. (JAMA Pediatr. Published online February 18, 2013. doi:10.1001/jamapediatrics.2013.633. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: This work was supported by the National Medical and Health Research Council of Australia. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Editorial: Neonatal Lung Function, Later Consequences

In a related editorial, Kai-Hkon Carlsen, M.D., Ph.D., of Oslo University Hospital, Norway, writes: "Mullane and colleagues present the results from an 18-year follow-up of a birth cohort recruited in Perth, Western Australia, during the late 1980s."

"The study by Mullane et al in the present issue of JAMA Pediatrics gives additional evidence to the finding that reduced lung function in early life has an important impact on later respiratory health. Taken together with the other studies cited, we may perhaps take away the message from the statement by Burrows and Taussig: 'As the twig is bent, the tree inclines.'"

(JAMA Pediatr. Published online February 18, 2013. doi:10.1001/jamapediatrics.2013.119. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.


'/>"/>
Contact: Steve W. Turner, M.D.
s.w.turner@abdn.ac.uk
JAMA and Archives Journals
Source:Eurekalert

Related medicine news :

1. Doctors fail to communicate impact of heart devices with patients, SLU study finds
2. U.S. Plans Billion-Dollar Project to Study the Brain
3. Women at Greater Risk for Hip Implant Failure, Study Finds
4. New study on Hepatitis C drug treatment in vivo and in vitro
5. Smoggy Air Tied to Heart Attacks: Study
6. Proscar Wont Boost Prostate Cancer Survival, Study Finds
7. Bel Marra Health Reports on a New Study: Body Image Influences Psychosocial Activities and Quality of Life.
8. New Study Finds Eating More Colorful Produce May Prevent or Delay ALS, Underscores Value of Health Enhancement Systems Program Design
9. MRSA Super Bug Prevalent in Nursing Homes, Study Finds
10. Study finds possible link between diabetes and increased risk of heart attack death
11. Rich/Poor Divide Linked to Hospital Readmissions in Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
Breaking Medicine Technology: